Local Production of Pharmaceuticals : Industrial Policy and Access to Medicines, An Overview of Key Concepts, Issues and Opportunities for Future Research
Local production of pharmaceuticals in developing countries may be seen as helping to stimulate industrial policy and/or as stimulating pharmaceutical access to needed medicines. However, if a developing country with manufacturing facilities is abl...
| Main Authors: | , |
|---|---|
| Format: | Working Paper |
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2013
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2005/01/5733898/local-production-pharmaceuticals-industrial-policy-access-medicines-overview-key-concepts-issues-opportunities-future-research http://hdl.handle.net/10986/13723 |
| id |
okr-10986-13723 |
|---|---|
| recordtype |
oai_dc |
| spelling |
okr-10986-137232021-04-23T14:03:09Z Local Production of Pharmaceuticals : Industrial Policy and Access to Medicines, An Overview of Key Concepts, Issues and Opportunities for Future Research Kaplan, Warren Laing, Richard ADVERTISING ANTIBIOTICS ANTIHISTAMINES BENCHMARKING CHEMISTS COMMUNICABLE DISEASES COMPETITIVE ADVANTAGE COMPETITIVENESS CRIME DEPRESSANTS DEVELOPED COUNTRIES DIABETES DRUG MANUFACTURING DRUG POLICIES ECONOMIC DEVELOPMENT ECONOMIC WELFARE ECONOMIC TRADE ECONOMICS ECONOMIES OF SCALE EFFECTIVE USE EMPLOYMENT EQUIPMENT ESSENTIAL DRUGS EXPORTS FINANCIAL SECTOR FUTURE RESEARCH GENERIC PRODUCTS GMP HEALTH HEALTH CARE HEALTH POLICY HEALTH SERVICES HIV/AIDS HOLIDAYS HORMONES HOSPITALS HUMAN DEVELOPMENT IMPORTS INCOME INDUSTRIALIZATION INFECTIOUS DISEASES INFLATION INSULIN LOCAL PHARMACEUTICAL PRODUCTION LOCAL PRODUCTION MALARIA MEDICINE MEDICINES MIDDLE INCOME COUNTRIES NATIONAL DRUG POLICY NUTRITION PATENTS PATIENTS PHARMACEUTICAL DOSAGE FORMS PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURE PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PRODUCTS PHARMACEUTICALS PHARMACY POLICY POLITICAL ECONOMY PRIVATE SECTOR PRODUCERS PROPERTY RIGHTS PUBLIC HEALTH PUBLIC SECTOR PURCHASING POWER QUALITY CONTROL REGULATORY SYSTEMS RESEARCH AGENDA SOLVENTS STIMULANTS SUPPLY DEMAND TAX RATES TRADE BALANCE TRADITIONAL MEDICINES VACCINES VALUE ADDED VITAMINS WORKERS Local production of pharmaceuticals in developing countries may be seen as helping to stimulate industrial policy and/or as stimulating pharmaceutical access to needed medicines. However, if a developing country with manufacturing facilities is able to finish off bulk active ingredients sourced from developed or other countries at high costs, such manufacture may have no impact whatever on patient access to needed medicines. There has been some critical thinking in the past regarding whether or not small developing countries should make their own pharmaceuticals, but no recent comprehensive summary of the issues and policy options. This paper summarizes the issues surrounding local production from a policy and public health viewpoint. It provides four brief country-level case studies, and reviews the evidence supporting the industrial policy assumptions underlying the goal of local production. In brief, in many parts of the world, producing medicines domestically makes little economic sense. If many countries begin local production, the result may be less access to medicines, since economies of scale may be lost if there are production facilities in many countries. The document concludes by providing a research agenda specifically designed to test assumptions about local production of pharmaceuticals. 2013-05-30T19:44:53Z 2013-05-30T19:44:53Z 2005-01 http://documents.worldbank.org/curated/en/2005/01/5733898/local-production-pharmaceuticals-industrial-policy-access-medicines-overview-key-concepts-issues-opportunities-future-research http://hdl.handle.net/10986/13723 English en_US Health, Nutrition and Population (HNP) discussion paper; CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/ World Bank World Bank, Washington, DC Publications & Research :: Working Paper Publications & Research |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English en_US |
| topic |
ADVERTISING ANTIBIOTICS ANTIHISTAMINES BENCHMARKING CHEMISTS COMMUNICABLE DISEASES COMPETITIVE ADVANTAGE COMPETITIVENESS CRIME DEPRESSANTS DEVELOPED COUNTRIES DIABETES DRUG MANUFACTURING DRUG POLICIES ECONOMIC DEVELOPMENT ECONOMIC WELFARE ECONOMIC TRADE ECONOMICS ECONOMIES OF SCALE EFFECTIVE USE EMPLOYMENT EQUIPMENT ESSENTIAL DRUGS EXPORTS FINANCIAL SECTOR FUTURE RESEARCH GENERIC PRODUCTS GMP HEALTH HEALTH CARE HEALTH POLICY HEALTH SERVICES HIV/AIDS HOLIDAYS HORMONES HOSPITALS HUMAN DEVELOPMENT IMPORTS INCOME INDUSTRIALIZATION INFECTIOUS DISEASES INFLATION INSULIN LOCAL PHARMACEUTICAL PRODUCTION LOCAL PRODUCTION MALARIA MEDICINE MEDICINES MIDDLE INCOME COUNTRIES NATIONAL DRUG POLICY NUTRITION PATENTS PATIENTS PHARMACEUTICAL DOSAGE FORMS PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURE PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PRODUCTS PHARMACEUTICALS PHARMACY POLICY POLITICAL ECONOMY PRIVATE SECTOR PRODUCERS PROPERTY RIGHTS PUBLIC HEALTH PUBLIC SECTOR PURCHASING POWER QUALITY CONTROL REGULATORY SYSTEMS RESEARCH AGENDA SOLVENTS STIMULANTS SUPPLY DEMAND TAX RATES TRADE BALANCE TRADITIONAL MEDICINES VACCINES VALUE ADDED VITAMINS WORKERS |
| spellingShingle |
ADVERTISING ANTIBIOTICS ANTIHISTAMINES BENCHMARKING CHEMISTS COMMUNICABLE DISEASES COMPETITIVE ADVANTAGE COMPETITIVENESS CRIME DEPRESSANTS DEVELOPED COUNTRIES DIABETES DRUG MANUFACTURING DRUG POLICIES ECONOMIC DEVELOPMENT ECONOMIC WELFARE ECONOMIC TRADE ECONOMICS ECONOMIES OF SCALE EFFECTIVE USE EMPLOYMENT EQUIPMENT ESSENTIAL DRUGS EXPORTS FINANCIAL SECTOR FUTURE RESEARCH GENERIC PRODUCTS GMP HEALTH HEALTH CARE HEALTH POLICY HEALTH SERVICES HIV/AIDS HOLIDAYS HORMONES HOSPITALS HUMAN DEVELOPMENT IMPORTS INCOME INDUSTRIALIZATION INFECTIOUS DISEASES INFLATION INSULIN LOCAL PHARMACEUTICAL PRODUCTION LOCAL PRODUCTION MALARIA MEDICINE MEDICINES MIDDLE INCOME COUNTRIES NATIONAL DRUG POLICY NUTRITION PATENTS PATIENTS PHARMACEUTICAL DOSAGE FORMS PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURE PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL PRODUCTS PHARMACEUTICALS PHARMACY POLICY POLITICAL ECONOMY PRIVATE SECTOR PRODUCERS PROPERTY RIGHTS PUBLIC HEALTH PUBLIC SECTOR PURCHASING POWER QUALITY CONTROL REGULATORY SYSTEMS RESEARCH AGENDA SOLVENTS STIMULANTS SUPPLY DEMAND TAX RATES TRADE BALANCE TRADITIONAL MEDICINES VACCINES VALUE ADDED VITAMINS WORKERS Kaplan, Warren Laing, Richard Local Production of Pharmaceuticals : Industrial Policy and Access to Medicines, An Overview of Key Concepts, Issues and Opportunities for Future Research |
| relation |
Health, Nutrition and Population (HNP)
discussion paper; |
| description |
Local production of pharmaceuticals in
developing countries may be seen as helping to stimulate
industrial policy and/or as stimulating pharmaceutical
access to needed medicines. However, if a developing country
with manufacturing facilities is able to finish off bulk
active ingredients sourced from developed or other countries
at high costs, such manufacture may have no impact whatever
on patient access to needed medicines. There has been some
critical thinking in the past regarding whether or not small
developing countries should make their own pharmaceuticals,
but no recent comprehensive summary of the issues and policy
options. This paper summarizes the issues surrounding local
production from a policy and public health viewpoint. It
provides four brief country-level case studies, and reviews
the evidence supporting the industrial policy assumptions
underlying the goal of local production. In brief, in many
parts of the world, producing medicines domestically makes
little economic sense. If many countries begin local
production, the result may be less access to medicines,
since economies of scale may be lost if there are production
facilities in many countries. The document concludes by
providing a research agenda specifically designed to test
assumptions about local production of pharmaceuticals. |
| format |
Publications & Research :: Working Paper |
| author |
Kaplan, Warren Laing, Richard |
| author_facet |
Kaplan, Warren Laing, Richard |
| author_sort |
Kaplan, Warren |
| title |
Local Production of Pharmaceuticals : Industrial Policy and Access to Medicines, An Overview of Key Concepts, Issues and Opportunities for Future Research |
| title_short |
Local Production of Pharmaceuticals : Industrial Policy and Access to Medicines, An Overview of Key Concepts, Issues and Opportunities for Future Research |
| title_full |
Local Production of Pharmaceuticals : Industrial Policy and Access to Medicines, An Overview of Key Concepts, Issues and Opportunities for Future Research |
| title_fullStr |
Local Production of Pharmaceuticals : Industrial Policy and Access to Medicines, An Overview of Key Concepts, Issues and Opportunities for Future Research |
| title_full_unstemmed |
Local Production of Pharmaceuticals : Industrial Policy and Access to Medicines, An Overview of Key Concepts, Issues and Opportunities for Future Research |
| title_sort |
local production of pharmaceuticals : industrial policy and access to medicines, an overview of key concepts, issues and opportunities for future research |
| publisher |
World Bank, Washington, DC |
| publishDate |
2013 |
| url |
http://documents.worldbank.org/curated/en/2005/01/5733898/local-production-pharmaceuticals-industrial-policy-access-medicines-overview-key-concepts-issues-opportunities-future-research http://hdl.handle.net/10986/13723 |
| _version_ |
1764424043454267392 |